HCPLive Network
Latest Oncology Headlines
Thursday, October 30, 2014
Women who survive breast cancer face a higher risk of depression that can linger and require antidepressants, according to a new study published online Oct. 27 in the Journal of Clinical Oncology
Thursday, October 30, 2014
Competition between medical practices helps keep health care costs lower, according to a study published in the Oct. 22/29 issue of the Journal of the American Medical Association.
Thursday, October 30, 2014
By Christina Izzo
New data being presented at the 84th Annual Meeting of the American Thyroid Association show promise for two molecular tests that help identify indeterminate thyroid nodules as either benign or malignant.
Thursday, October 30, 2014
Combined biennial digital mammography and tomosynthesis screening is effective for women with dense breasts, according to a study published online Oct. 28 in Radiology.
Wednesday, October 29, 2014
By Gale Scott
Family practice has a reputation for being a low-tech, hands-on specialty. But speaking in a keynote address at the American Academy of Family Physicians Assembly Oct. 26 , Eric Topol, MD told his audience they would do well to use more technologically sophisticated devices.
Wednesday, October 29, 2014
By HCPLive staff
Researchers have found that a simple blood test might help diagnose pancreatic cancer, one of the most deadly forms of the disease.
Wednesday, October 29, 2014
By Maurie Markman, MD
It is increasingly recognized that the era of treating individual advanced or metastatic cancers based essentially on the anatomic site of origin or histologic subtype as determined by light microscopic evaluation is rapidly coming to a close.
Wednesday, October 29, 2014
Adoption of noneconomic damages caps reduces average malpractice payments by 15 percent, according to research published in the October issue of Health Affairs.
Wednesday, October 29, 2014
By Jeannette Y. Wick, RPh, MBA, FASCP
Laparoscopic interventions for rectal cancer are controversial. Oncologists have concerns about high conversion rates and long operating times associated with laparoscopic total mesorectal excision (TME), and they worry that laparoscopic TME violates the principle of sharp mesorectal dissection.
Wednesday, October 29, 2014
The US Preventive Services Task Force has concluded that there is currently insufficient evidence to assess the benefits and harms of thyroid screening. These findings form the basis of a draft recommendation statement based on an evidence review published online Oct. 28 in the Annals of Internal Medicine.
Wednesday, October 29, 2014
By Andrew J. Roth
The treatment of cancer is complex, and what might seem like a relatively minor medical issue at first can quickly escalate into an emergency.
Wednesday, October 29, 2014
Exercising, eating a healthy diet, and learning relaxation techniques before colorectal cancer surgery appear to speed a patient's recovery, according to a small study published in the November issue of Anesthesiology.
Tuesday, October 28, 2014
By Jane de Lartigue, PhD
Despite being discovered more than 150 years ago, tumor cells present in the blood of patients with cancer are only now inspiring significant research efforts. Technological advancements have allowed the isolation and enrichment of these rare cells and, as potential metastatic “emissaries,” they have significant potential for improving the detection and treatment of advanced and possibly even early-stage disease.
Tuesday, October 28, 2014
Radiologists' screening performance improves with work-up of their own recalled screening mammograms, according to a study published in the November issue of Radiology.
Tuesday, October 28, 2014
By Andrew J. Roth
Mutations known to be involved in hematologic malignancies were found in the blood cells of 2%-3% of individuals over age 40 and 5%-6% of those over age 70.
Monday, October 27, 2014
By Sandra Kear
The FDA has granted a breakthrough therapy designation to pembrolizumab (Keytruda), an anti-PD-1 therapy, for the treatment of patients with non-small cell lung cancer (NSCLC) who are EGFR mutation- or ALK rearrangement-negative and whose disease has progressed on or following platinum-based chemotherapy.
Monday, October 27, 2014
By Beth Fand Incollingo
From a limited first meeting in the late 1990s that included the leaders of a dozen large group practices, LUGPA has grown so much that its annual meeting this November will include up to 550 physicians and 200 administrators, filling the organization’s usual Chicago venue to capacity and necessitating a move to a larger space next year.
Sunday, October 26, 2014
By Christina Izzo
Suresh S. Ramalingam, MD, discusses results from a phase II trial exploring the potential of veliparib as a treatment for patients with squamous cell NSCLC.
Saturday, October 25, 2014
By Beth Fand Incollingo
A round-up of new drugs that are being investigated as treatments for genitourinary cancers.
Friday, October 24, 2014
By Leonard G. Gomella, MD
The 12-month countdown to the adoption of ICD-10 has begun. ICD-10 represents the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (usually referred to as “ICD”), now overseen by the World Health Organization (WHO).
Physician's Money Digest
There have been quite a few hot IPOs this year. Alibaba and GoPro to name just a couple. But the real money was made before these companies even went public.
Medical school enrollment in the US has hit an all-time high, according to data from the Association of American Medical Colleges. The data also show medical schools continue to become more diverse.